Morning Joe co-host Mika Brzezinski suggested President Trump may have a financial incentive to push the anti-malaria drug being touted as a possible treatment for coronavirus patients.
Trump, along with his economic adviser Peter Navarro, personal lawyer Rudy Giuliani, and other confidants, has praised hydroxychloroquine, while medical experts, including those on his coronavirus task force, have cautioned there was still a lack of solid evidence showing it is effective against the COVID-19 virus.
Brzezinski and husband Joe Scarborough opened their MSNBC show on Monday with a discussion on the warring factions in the White House after Axios reported Navarro and Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, clashed over hydroxychloroquine. Scarborough repeatedly called it an “unproven drug” and said it “doesn’t work for” the virus. Brzezinski accused Trump of being involved with the drug monetarily to explain his support for the drug.
“A lot of people would say, follow the money,” she said. “There’s got to be some sort of financial tie to someone somewhere that has the president pushing this repeatedly.”
Scarborough questioned why cable news outlets were still broadcasting the near-daily White House coronavirus task force briefings at which the president promotes the “unproven drug.”
At a White House coronavirus task force briefing on Sunday, Trump announced the administration had purchased “a tremendous amount” of hydroxychloroquine, which will be distributed to the states after the Food and Drug Administration issued an emergency approval for its use among coronavirus patients. The president has touted the drug as a possible treatment to the coronavirus, despite a lack of evidence.
“We have it stockpiled — about 29 million doses. We have a lot of it. We hope it works,” Trump said.
Author: Mike Brest
Source: Washington Examiner: MSNBC’s Mika Brzezinski suspects ‘financial tie’ has Trump pushing anti-malaria drug